Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI ACWI ETF
ACWI
|
+$825M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$813M |
| 3 |
Direxion Daily 20+ Year Treasury Bull 3X ETF
TMF
|
+$802M |
| 4 |
iShares MSCI India ETF
INDA
|
+$743M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$704M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.37B |
| 2 |
Microsoft
MSFT
|
+$2.08B |
| 3 |
NVIDIA
NVDA
|
+$1.74B |
| 4 |
Amazon
AMZN
|
+$1.08B |
| 5 |
Netflix
NFLX
|
+$803M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.41% |
| 2 | Consumer Discretionary | 1.14% |
| 3 | Financials | 1.02% |
| 4 | Healthcare | 0.75% |
| 5 | Industrials | 0.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8576
ADS-TEC Energy Warrant
ADSEW
| $66.9K | ﹤0.01% |
+30,902
| New | +$42.5K |
|
8577
PUT
Sundial Growers
SNDL
$318M
| $66.8K | ﹤0.01% |
+33,300
| New | +$48.6K |
|
8578
Atomera
ATOM
$210M
| $66.5K | ﹤0.01% |
10,796
-7,507
| -41% | -$51.5K |
|
8579
CALL
Solid Power
SLDP
$536M
| $63.9K | ﹤0.01% |
+31,500
| New | +$48K |
|
|
ONL
8580
Orion Office REIT
ONL
$156M
| $63.9K | ﹤0.01% |
18,193
-305,073
| -94% | -$1.37M |
|
|
AKYA
8581
DELISTED
Akoya BioSciences
AKYA
| $63.1K | ﹤0.01% |
13,447
-8,623
| -39% | -$44.8K |
|
|
YALA
8582
Yalla Group
YALA
$820M
| $63K | ﹤0.01% |
13,107
-45,457
| -78% | -$234K |
|
8583
IHS Holding
IHS
$2.79B
| $63K | ﹤0.01% |
17,852
+6,956
| +64% | +$23.7K |
|
|
PAYOW
8584
DELISTED
Payoneer Global Inc. Warrant
PAYOW
| $62.9K | ﹤0.01% |
233,000
-938
| -0.4% | -$274 |
|
|
KYNB
8585
CALL
Kyntra Bio
KYNB
$28.2M
| $62.5K | ﹤0.01% |
1,064
+248
| +30% | +$10.7K |
|
|
ASXC
8586
DELISTED
Asensus Surgical, Inc.
ASXC
| $61.9K | ﹤0.01% |
269,012
+221,372
| +465% | +$64.3K |
|
8587
Sensus Healthcare
SRTS
$50.9M
| $61.8K | ﹤0.01% |
16,274
+510
| +3% | +$1.85K |
|
|
SPRB
8588
Spruce Biosciences
SPRB
$127M
| $61.7K | ﹤0.01% |
+1,047
| New | +$266K |
|
8589
CALL
Genius Sports
GENI
$2.1B
| $61.7K | ﹤0.01% |
10,800
-69,500
| -87% | -$446K |
|
8590
Custom Truck One Source
CTOS
$2.42B
| $61.6K | ﹤0.01% |
10,581
-16,892
| -61% | -$105K |
|
|
SAND
8591
PUT
DELISTED
Sandstorm Gold
SAND
| $61.4K | ﹤0.01% |
11,700
-11,500
| -50% | -$53.2K |
|
8592
PUT
Rigetti Computing
RGTI
$5.89B
| $61.2K | ﹤0.01% |
40,000
+20,600
| +106% | +$29.7K |
|
|
ETWO
8593
DELISTED
E2open Parent Holdings
ETWO
| $61K | ﹤0.01% |
13,733
-137,913
| -91% | -$557K |
|
8594
TMC The Metals Company
TMC
$1.92B
| $60.7K | ﹤0.01% |
42,452
+14,445
| +52% | +$20.1K |
|
8595
Sight Sciences
SGHT
$424M
| $59.9K | ﹤0.01% |
11,341
-59,195
| -84% | -$278K |
|
8596
CALL
Pitney Bowes
PBI
$2.33B
| $59.8K | ﹤0.01% |
+13,800
| New | +$56.9K |
|
8597
Rimini Street
RMNI
$458M
| $59.7K | ﹤0.01% |
18,308
-22,419
| -55% | -$71.6K |
|
8598
Amprius Technologies
AMPX
$1.73B
| $59.4K | ﹤0.01% |
22,433
-5,478
| -20% | -$20.3K |
|
|
AEON.WS
8599
DELISTED
AEON Biopharma Inc
AEON.WS
| $59.2K | ﹤0.01% |
40,825
+363
| +0.9% | +$223 |
|
8600
Trevi Therapeutics
TRVI
$2.54B
| $59K | ﹤0.01% |
17,094
-48,859
| -74% | -$109K |
|
Similar funds
Jane Street's Q1 2024 Portfolio in Review
As of Q1 2024, Jane Street held 10,498 positions worth $478B, up 25% from $384B the previous quarter. Its ten largest holdings account for 51% of the portfolio.
Jane Street deployed $55.3B of net new capital in Q1 2024, opening 1,391 new positions and adding to 3,225 existing holdings. Its largest new stake was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
By sector, the portfolio is most concentrated in Technology at 2.4% of assets, down from 4.4% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.37B trimmed.
- Jane Street's largest Q1 2024 buy was iShares MSCI EAFE Value ETF: 9,907,136 shares worth $539M.
- Jane Street added most to iShares MSCI ACWI ETF in Q1 2024, an estimated $825M increase.
- Jane Street's biggest Q1 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.37B.
- Jane Street fully exited JPMorgan Ultra-Short Income ETF in Q1 2024, selling an estimated $302M.
- Jane Street's ten largest holdings make up 51% of its $478B portfolio in Q1 2024.
- Jane Street opened 1,391 new positions and closed 1,402 in Q1 2024.
- Jane Street's portfolio value rose 25% quarter-over-quarter to $478B.
Based on Jane Street's 13F filing for Q1 2024, filed 16 May 2024.